Method for introducing a PNA molecule conjugated to a positively charged peptide into the cytosol and/or the nucleus by photochemical internalisation (PCI)

Details for Australian Patent Application No. 2005258975 (hide)

Owner PCI Biotech AS

Inventors Boe, Sigurd; Fodstad, Oystein; Hovig, Eivind

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005258975

PCT Pub. Number WO2006/003463

Priority 0415263.3 07.07.04 GB

Filing date 7 July 2005

Wipo publication date 12 January 2006

Acceptance publication date 10 November 2011

International Classifications

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

15 February 2007 PCT application entered the National Phase

  PCT publication WO2006/003463 Priority application(s): WO2006/003463

2 April 2009 Assignment before Grant

  The Norwegian Radium Hospital Research Foundation The application has been assigned to PCI Biotech AS

10 November 2011 Application Accepted

  Published as AU-B-2005258975

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005258980-Improved well servicing tool storage system for subsea well intervention

2005258973-Polypeptide